{"bill": {"@star-print": "no-star-print", "#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "@display": "no", "#text": "IN THE SENATE OF THE UNITED STATES"}, "enrolled-dateline": {"#tail": "\n    ", "@display": "yes", "#text": "Begun and held at the City of Washington on Friday, the third day of January, two thousand and\n\t\t\t fourteen"}, "congress": {"#tail": "\n    ", "#text": "One Hundred Thirteenth Congress of the United States of America"}, "#tail": "\n  ", "#text": "\n", "legis-num": {"#tail": "\n    ", "@display": "yes", "#text": "S. 2917"}, "official-title": {"#tail": "\n  ", "@display": "yes", "#text": "To expand the program of priority review to encourage treatments for tropical diseases.  "}, "@display": "yes", "session": {"#tail": "\n    ", "@display": "yes", "#text": "2d Session"}, "legis-type": {"#tail": "\n    ", "@display": "yes", "#text": "AN ACT"}}, "attestation": {"#tail": "\n", "attestation-group": [{"#tail": "\n    ", "role": {"#tail": "\n    ", "#text": "Speaker of the House of Representatives"}, "#text": "\n      ", "attestor": {"#tail": "\n      ", "@display": "no"}}, {"#tail": "\n  ", "role": {"#tail": "\n    ", "#text": "Vice President of the United States and President of the Senate"}, "#text": "\n      ", "attestor": {"#tail": "\n      ", "@display": "no"}}], "#text": "\n    "}, "@stage-count": "1", "@bill-stage": "Enrolled-Bill", "@bill-type": "olc", "@dms-id": "A1", "@public-private": "public", "legis-body": {"#tail": "\n  ", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Adding Ebola to the FDA Priority Review Voucher Program Act", "@value": "Adding Ebola to the FDA Priority Review Voucher Program Act", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title", "@display-inline": "yes-display-inline"}, "@display-inline": "no-display-inline", "#text": "\n      ", "@id": "S1", "@commented": "no"}, {"@section-type": "subsequent-section", "#tail": "\n  ", "text": {"#tail": "\n      ", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 524 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:524"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 360n", "@value": "usc/21/360n"}, "@parsable-cite": "usc/21/360n", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Priority review to encourage treatments for tropical diseases", "@display-inline": "yes-display-inline"}, "paragraph": [{"@id": "idE49BCCB76D8B4A9FAB3630A41EFE8199", "#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "in subsection (a)(3)\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@display-inline": "no-display-inline", "#text": "\n        ", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "by redesignating subparagraph (Q) as subparagraph (R);", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "idAA07FBC2ED85428E865A091CE17C5862", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "by inserting after subparagraph (P) the following:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "; and"}, "#tail": "\n        ", "@id": "id10673255AEBC4BE3A7DF7D617AE81911", "@display-inline": "no-display-inline", "#text": "\n            ", "subparagraph": {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "Filoviruses.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(Q)"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id7F814DCACA9B46E993BAD77D0E40A7D4", "@commented": "no"}}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id16A78F9A04DB4C55AB10E3AC20548949", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "quote": [{"#tail": " and inserting ", "#text": "regulation by"}, {"#tail": "; and", "#text": "order of"}], "#text": "in subparagraph (R), as so redesignated, by striking ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "idA3718C1E988343D4952CCF46F5B64EAF", "@commented": "no"}], "@commented": "no"}, {"@id": "idE7874CA2ED7E49C9A4CED53DE1BDA117", "#tail": "\n    ", "text": {"#tail": "\n        ", "#text": "in subsection (b)\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@display-inline": "no-display-inline", "#text": "\n        ", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "quote": {"#tail": " after the period at the end; and", "#text": "There is no limit on the number of times a priority review voucher may be transferred before such\n\t\t\t voucher is used."}, "#text": "in paragraph (2), by adding ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "idCCD0528AE3A945F895A04B573AFCC0A4", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "quote": [{"#tail": " and inserting ", "#text": "365 days"}, {"#tail": ".", "#text": "90 days"}], "#text": "in paragraph (4), by striking ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id5AF8FF406045498DA9E2427B97DB741B", "@commented": "no"}], "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n      ", "@id": "id0FB2205E53A34A4B85A62C8391E370CF", "@commented": "no"}], "#text": "\n    ", "@display-enacting-clause": "yes-display-enacting-clause"}, "@public-print": "no", "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": " S2917 ENR: Adding Ebola to the FDA Priority Review Voucher Program Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}